The Value of Thromboelastography (TEG) in COVID-19 Critical Illness as Illustrated by a Case Series

               Thromboelastography

Thromboelastography (TEG) is a technique for determining blood coagulation efficiency.

It's a test that's mostly utilized in surgery and anesthesia, but it's also becoming more used in resuscitations in ERs, ICUs, and labor and delivery rooms.

OBJECTIVE: To provide a realistic thromboelastography-guided (TEG) anticoagulation program for COVID-19 critically unwell patients.

DESIGN: A multidisciplinary team looked at the current research on hypercoagulability in critically ill COVID-19 patients, clinical care strategies, and the problems of high rates of thrombotic events despite anticoagulant therapy.

SETTING: The Northwell Health System's largest tertiary care hospital in New York.

COVID-19 patients who were mechanically ventilated invasively in Medical Intensive Care Units.

TEG was measured in COVID-19 patients who were critically unwell.

Patterns were examined to design a treatment strategy based on TEG characteristics for anticoagulant therapy selection.

Three patients are said to have highlighted TEG characteristics, which led to the algorithm's development.

With cooperation from intensivists, the clinical trajectory and treatment decisions were collected retrospectively from the Electronic Health Record.

The use of anticoagulants, laboratory and TEG results and venous/arterial lower extremity (LE) ultrasonography results were also documented.

PRIMARY Findings: Despite preventive or therapeutic doses of unfractionated heparin or low-molecular-weight heparin, these patients had hypercoagulable TEG results (LMHW).

Thromboelastography provides patient-specific evidence for a hypercoagulable state in patients receiving anticoagulant medication of any kind.

Thromboelastography (TEG) is a viscoelastic hemostatic technique that assesses the viscoelastic features of blood clot formation.

It's mostly utilized in anesthesia and surgery.

The test can assess the function of coagulation factors.

The partial thromboplastin time (aPTT) and prothrombin time are two more blood coagulation tests.

Thromboelastography, on the other hand, provides information on all hemostasis components, including platelet function and coagulation.